Agreed on the whole, but seems like ERX is nearing its prior double-top peak of early NOV 2009, whereas FAS is forming a lower high.
Additionally, market may carry some "contagious" effects of well-performers, stunting further growth prospect, IMHO.
I very much like your relative strength charting of NYUPV against NYTV. It seems that the chart would potentially decipher true momental advances vs. uncommitted advances where the volume fails. Nice.
I wish there was a formula that would allow the product of the two ("NYUPV x NYTV), to highlight the amplifying effect of volume on advancing stocks as well.